Docetaxel extravasation

Author： Berghammer P. Pöhnl R. Baur M. Dittrich C.

ISSN： 0941-4355

Source： Supportive Care in Cancer, Vol.9, Iss.2, 2001-03, pp. : 131-134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Docetaxel Extravasation Causing Significant Delayed Tissue Injury

By Raley J. Geisler J.P. Buekers T.E. Sorosky J.I.

Gynecologic Oncology, Vol. 78, Iss. 2, 2000-08 ,pp. : 259-260

Elsevier

Access to resources Recommend Favorite

Docetaxel extravasation results in significantly delayed and relapsed skin injury: A case report

Oncology Letters, Vol. 7, Iss. 5, 2014-01 ,pp. : 1497-1498

Spandidos Publications

Access to resources Recommend Favorite

A sarcoma at the site of previous extravasation of adriamycin

By Ceulemans Joris Dewever Ivo Sciot Raf Debiec-Rychter Maria van Oosterom Allan T.

Sarcoma, Vol. 6, Iss. 4, 2002-12 ,pp. : 135-139

Informa Healthcare

Access to resources Recommend Favorite

Organ-specificity of the extravasation process: An ultrastructural study

By Paku S. Döme B. Tóth R. Timár J.

Clinical and Experimental Metastasis, Vol. 18, Iss. 6, 2001-06 ,pp. : 481-492

Springer Publishing Company

Access to resources Recommend Favorite

Dexrazoxane use in the prevention of anthracycline extravasation injury

By Hasinoff Brian B

Future Oncology, Vol. 2, Iss. 1, 2006-02 ,pp. : 15-20

Future Medicine

Access to resources Recommend Favorite